Finance

MUYUAN(02714.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 6.08 billion, turned into a loss from a profit YoY - NewTimeSpace
MUYUAN(02714.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 6.08 billion, turned into a loss from a profit YoY

NewTimeSpace News: August 20, 2026, MUYUAN(02714.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 59.41 billion, decreased by 22.3% YoY.

2026-08-21
Muyuan02714.HKturned into a loss from a profit
EMPEROR WATCH&J(00887.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 310.43 million, YoY increase of 58% - NewTimeSpace
EMPEROR WATCH&J(00887.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 310.43 million, YoY increase of 58%

NewTimeSpace News: August 20, 2026, EMPEROR WATCH&J(00887.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.93 billion, increased by 5.03% YoY.

2026-08-21
EMPEROR WATCH&J00887.HKprofit growth
ZYLOXTB(02190.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 181.71 million, YoY increase of 49.93% - NewTimeSpace
ZYLOXTB(02190.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 181.71 million, YoY increase of 49.93%

NewTimeSpace News: August 20, 2026, ZYLOXTB(02190.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 632.04 million, increased by 31.14% YoY.

2026-08-21
ZYLOXTB02190.HKprofit growth
PAK FAH YEOW(00239.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 47.35 million, YoY increase of 19.15% - NewTimeSpace
PAK FAH YEOW(00239.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 47.35 million, YoY increase of 19.15%

NewTimeSpace News: August 20, 2026, PAK FAH YEOW(00239.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 101.04 million, increased by 6.65% YoY.

2026-08-21
PAK FAH YEOW00239.HKprofit growth
GUOXIA TECH(02655.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 60.55 million, YoY increase of 986.04% - NewTimeSpace
GUOXIA TECH(02655.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 60.55 million, YoY increase of 986.04%

NewTimeSpace News: August 20, 2026, GUOXIA TECH(02655.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.43 billion, increased by 106.45% YoY.

2026-08-21
GUOXIA TECH02655.HKprofit growth
APEX ACE HLDG(06036.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 134.04 million, YoY increase of 1149.28% - NewTimeSpace
APEX ACE HLDG(06036.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 134.04 million, YoY increase of 1149.28%

NewTimeSpace News: August 20, 2026, APEX ACE HLDG(06036.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 4.97 billion, increased by 126.25% YoY.

2026-08-21
APEX ACE HLDG06036.HKprofit growth
ZHOU HEI YA(01458.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 91.5 million, YoY decrease of 15.23% - NewTimeSpace
ZHOU HEI YA(01458.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 91.5 million, YoY decrease of 15.23%

NewTimeSpace News: August 20, 2026, ZHOU HEI YA(01458.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.46 billion, increased by 19.53% YoY.

2026-08-21
ZHOU HEI YA01458.HKProfit declined
MAOYAN ENT(01896.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 27.59 million, turned into a loss from a profit YoY - NewTimeSpace
MAOYAN ENT(01896.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 27.59 million, turned into a loss from a profit YoY

NewTimeSpace News: August 20, 2026, MAOYAN ENT(01896.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.79 billion, decreased by 27.6% YoY.

2026-08-21
MAOYAN ENT01896.HKturned into a loss from a profit
SIMCERE PHARMA(02096.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 828.72 million, YoY increase of 37.88% - NewTimeSpace
SIMCERE PHARMA(02096.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 828.72 million, YoY increase of 37.88%

NewTimeSpace News: August 20, 2026, SIMCERE PHARMA(02096.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 4.58 billion, increased by 27.76% YoY.

2026-08-21
SIMCERE PHARMA02096.HKprofit growth
JLMAG(06680.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 462.24 million, YoY increase of 51.58% - NewTimeSpace
JLMAG(06680.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 462.24 million, YoY increase of 51.58%

NewTimeSpace News: August 20, 2026, JLMAG(06680.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 4.65 billion, increased by 32.57% YoY.

2026-08-21
JLMAG06680.HKprofit growth
BLUE MOON GROUP(06993.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 192.47 million, loss narrowed by 55.79% YoY - NewTimeSpace
BLUE MOON GROUP(06993.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 192.47 million, loss narrowed by 55.79% YoY

NewTimeSpace News: August 20, 2026, BLUE MOON GROUP(06993.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.88 billion, decreased by 5.07% YoY.

2026-08-21
BLUE MOON GROUP06993.HKloss narrowed
LIULIUMEI(06658.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 140.87 million, YoY increase of 33.46% - NewTimeSpace
LIULIUMEI(06658.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 140.87 million, YoY increase of 33.46%

NewTimeSpace News: August 20, 2026, LIULIUMEI(06658.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.06 billion, increased by 10.63% YoY.

2026-08-21
Liuliumei06658.HKprofit growth
HYBRID KINETIC (01188.HK): enters into MOU with Hengwan New Energy on 5 GWh energy storage and power battery project - NewTimeSpace
HYBRID KINETIC (01188.HK): enters into MOU with Hengwan New Energy on 5 GWh energy storage and power battery project

NewTimeSpace News: On 20 August 2026, HYBRID KINETIC (01188.HK) voluntarily announced that it has entered into an MOU with Hengwan New Energy (Qianshan) Co., Ltd., intending to cooperate on advancing a 5 GWh per annum energy storage and power battery industrial project and jointly developing energy storage cells and power lithium-ion batteries; the cooperation remains indicative in nature and subject to legally binding definitive agreements.

2026-08-21
HYBRID KINETIC01188.HKstrategic cooperation
LUYE PHARMA (02186.HK): therapeutic mRNA vaccine LY01620 to initiate Phase II clinical trial in China, HPV viral clearance rate nearly 90% - NewTimeSpace
LUYE PHARMA (02186.HK): therapeutic mRNA vaccine LY01620 to initiate Phase II clinical trial in China, HPV viral clearance rate nearly 90%

NewTimeSpace News: On 20 August 2026, LUYE PHARMA (02186.HK) voluntarily announced that its therapeutic mRNA vaccine LY01620 is about to initiate a Phase II clinical trial in China for patients with HPV16-positive HSIL; the Phase I study showed an HPV viral clearance rate of nearly 90% and histological improvement approaching standard surgical levels, with the treatment being non-invasive and not affecting fertility.

2026-08-21
LUYE PHARMA02186.HKClinical Progress
HANKING GOLD (03788.HK): Wang Ping appointed Senior Independent Non-Executive Director - NewTimeSpace
HANKING GOLD (03788.HK): Wang Ping appointed Senior Independent Non-Executive Director

NewTimeSpace News: On 20 August 2026, HANKING GOLD (03788.HK) announced that Independent Non-Executive Director Wang Ping has been appointed as Senior Independent Non-Executive Director, effective 20 August 2026, primarily to facilitate communication among independent directors and with shareholders, especially minority shareholders; the position was introduced by reference to the amended Corporate Governance Code.

2026-08-21
HANKING GOLD03788.HKBoard Change
SIMCERE PHARMA (02096.HK): Zhu Da appointed Joint Company Secretary succeeding Wan Yushan, waiver granted from company secretary qualification requirements - NewTimeSpace
SIMCERE PHARMA (02096.HK): Zhu Da appointed Joint Company Secretary succeeding Wan Yushan, waiver granted from company secretary qualification requirements

NewTimeSpace News: On 21 August 2026, SIMCERE PHARMA (02096.HK) announced that Wan Yushan has ceased as Joint Company Secretary (remaining ED and CFO), with Board Secretary Zhu Da appointed in addition as his successor and granted a three-year waiver from company secretary qualification requirements (assisted by Mai Baowen); Mr. Zhu has over 12 years of investment banking and corporate management experience.

2026-08-21
SIMCERE PHARMA02096.HKBoard Change
Previous1..130131 132133134..356     356 pages total